Volume 21, Issue 70 (12-2020)                   Zanko J Med Sci 2020, 21(70): 69-71 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Payandeh M, Ahmadyani R, Karamian M H, Iranpanah A. Allogenic Bone Marrow Transplantation in an AML Patient with Cardiovascular Disease Background: A Case Study. Zanko J Med Sci. 2020; 21 (70) :69-71
URL: http://zanko.muk.ac.ir/article-1-525-en.html
Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract:   (387 Views)
Acute myeloid leukemia (AML) is defined by increase in the number of myeloid cell lineages in peripheral blood. There are several established protocols for curing AML, each with its own limitations. This paper is a brief report on successful treatment of a middle-aged female AML patient with cardiovascular disease background, by using Allogenic Bone Marrow Transplantatin
Full-Text [PDF 377 kb]   (112 Downloads)    
Type of Study: case report | Subject: Special
Received: 2020/09/4 | Accepted: 2020/10/1 | ePublished: 2020/12/30

Add your comments about this article : Your username or Email:

Send email to the article author

© 2021 All Rights Reserved | Zanko Journal of Medical Sciences

Designed & Developed by : Yektaweb